RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/17911475http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/17911475http://www.w3.org/2000/01/rdf-schema#comment"Interleukin-21 (IL-21) is a pleiotropic cytokine whose function is only now being unraveled. Abundant evidence indicates that activated CD4 T cells are the primary, if not the only, source of IL-21. While it is clear that IL-21 is actively transcribed by naïve activated T cells, recent studies have shown that IL-21 potentially promotes a developmental shift of naïve T cells toward the Th2 phenotype. BXSB-Yaa mice develop an autoimmune syndrome similar to systemic lupus erythematosus (SLE), affecting males earlier than females on account of the presence of the Yaa (Y-linked autoimmune acceleration) locus. Previous results indicate the elevation of IL-21 expression by BXSB-Yaa mice at an age when the early characteristics of autoimmune processes first become evident. We set out to determine whether IL-21 was necessary for disease progression in BXSB-Yaa mice. Mice were treated for 24 weeks with soluble IL-21R-Fc in order to therapeutically neutralize the IL-21 present. The results overall suggest a biphasic effect of IL-21, negatively influencing survival early on and positively influencing survival at later stages. We propose that IL-21 exerts a pleiotropic effect in which it promotes the protective effects of CD8+ suppressor cells in the early disease phase and then promotes the humoral components of SLE in the later disease stages. This experiment provides preliminary evidence for a role of IL-21 in modulating the severity of SLE in BXSB-Yaa mice."xsd:string
http://purl.uniprot.org/citations/17911475http://purl.org/dc/terms/identifier"doi:10.1196/annals.1423.063"xsd:string
http://purl.uniprot.org/citations/17911475http://purl.uniprot.org/core/author"Lyons B.L."xsd:string
http://purl.uniprot.org/citations/17911475http://purl.uniprot.org/core/author"Young D.A."xsd:string
http://purl.uniprot.org/citations/17911475http://purl.uniprot.org/core/author"Roopenian D.C."xsd:string
http://purl.uniprot.org/citations/17911475http://purl.uniprot.org/core/author"Olland S."xsd:string
http://purl.uniprot.org/citations/17911475http://purl.uniprot.org/core/author"Bennett S.M."xsd:string
http://purl.uniprot.org/citations/17911475http://purl.uniprot.org/core/author"Sproule T.J."xsd:string
http://purl.uniprot.org/citations/17911475http://purl.uniprot.org/core/author"Bubier J.A."xsd:string
http://purl.uniprot.org/citations/17911475http://purl.uniprot.org/core/date"2007"xsd:gYear
http://purl.uniprot.org/citations/17911475http://purl.uniprot.org/core/name"Ann N Y Acad Sci"xsd:string
http://purl.uniprot.org/citations/17911475http://purl.uniprot.org/core/pages"590-601"xsd:string
http://purl.uniprot.org/citations/17911475http://purl.uniprot.org/core/title"Treatment of BXSB-Yaa mice with IL-21R-Fc fusion protein minimally attenuates systemic lupus erythematosus."xsd:string
http://purl.uniprot.org/citations/17911475http://purl.uniprot.org/core/volume"1110"xsd:string
http://purl.uniprot.org/citations/17911475http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/17911475
http://purl.uniprot.org/citations/17911475http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/17911475
http://purl.uniprot.org/uniprot/#_Q3UBS8-mappedCitation-17911475http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/17911475
http://purl.uniprot.org/uniprot/#_Q3TA82-mappedCitation-17911475http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/17911475
http://purl.uniprot.org/uniprot/#_Q3TAI3-mappedCitation-17911475http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/17911475
http://purl.uniprot.org/uniprot/#_Q6PEU8-mappedCitation-17911475http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/17911475
http://purl.uniprot.org/uniprot/#_Q9JHX3-mappedCitation-17911475http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/17911475
http://purl.uniprot.org/uniprot/Q3TAI3http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/17911475
http://purl.uniprot.org/uniprot/Q9JHX3http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/17911475
http://purl.uniprot.org/uniprot/Q6PEU8http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/17911475